Title |
Antibiotics and antiseptics for venous leg ulcers
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2014
|
DOI | 10.1002/14651858.cd003557.pub5 |
Pubmed ID | |
Authors |
Susan O'Meara, Deyaa Al‐Kurdi, Yemisi Ologun, Liza G Ovington, Marrissa Martyn‐St James, Rachel Richardson |
Abstract |
Venous leg ulcers are a type of chronic wound affecting up to 1% of adults in developed countries at some point during their lives. Many of these wounds are colonised by bacteria or show signs of clinical infection. The presence of infection may delay ulcer healing. Two main strategies are used to prevent and treat clinical infection in venous leg ulcers: systemic antibiotics and topical antibiotics or antiseptics. |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 17 | 40% |
United Kingdom | 3 | 7% |
Portugal | 2 | 5% |
Dominican Republic | 1 | 2% |
New Zealand | 1 | 2% |
France | 1 | 2% |
Colombia | 1 | 2% |
Unknown | 17 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 36 | 84% |
Practitioners (doctors, other healthcare professionals) | 2 | 5% |
Science communicators (journalists, bloggers, editors) | 2 | 5% |
Scientists | 1 | 2% |
Unknown | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 607 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 3 | <1% |
Switzerland | 2 | <1% |
Brazil | 2 | <1% |
United Kingdom | 2 | <1% |
Norway | 1 | <1% |
United States | 1 | <1% |
Unknown | 596 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 82 | 14% |
Student > Bachelor | 76 | 13% |
Researcher | 71 | 12% |
Student > Ph. D. Student | 57 | 9% |
Other | 42 | 7% |
Other | 122 | 20% |
Unknown | 157 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 220 | 36% |
Nursing and Health Professions | 72 | 12% |
Agricultural and Biological Sciences | 29 | 5% |
Biochemistry, Genetics and Molecular Biology | 22 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 3% |
Other | 75 | 12% |
Unknown | 169 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#596,312
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,071
of 11,499 outputs
Outputs of similar age
#5,982
of 319,422 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 223 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,422 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 223 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.